FOURTH AMENDMENT TO LEASE AGREEMENTLease Agreement • July 31st, 2020 • Ultragenyx Pharmaceutical Inc. • Pharmaceutical preparations
THIS FOURTH AMENDMENT TO LEASE AGREEMENT (this “Fourth Amendment”) is made as of this 31st day of March, 2020, between ARE-MA REGION NO. 20, LLC, a Delaware limited liability company (“Landlord”), and ULTRAGENYX PHARMACEUTICAL INC., a Delaware corporation (“Tenant”).
EQUITY PURCHASE AGREEMENTUltragenyx Pharmaceutical Inc. • July 31st, 2020 • Pharmaceutical preparations • Delaware
THIS EQUITY PURCHASE AGREEMENT (this “Agreement”) is made as of June 18, 2019, by and among Ultragenyx Pharmaceutical Inc., a Delaware corporation (the “Investor”), Arcturus Therapeutics Ltd., an Israeli incorporated company (“Arcturus-Israel”), and Arcturus Therapeutics Holdings Inc., a newly incorporated Delaware corporation (“Arcturus-Delaware”).
THIRD AMENDMENT TO LEASE AGREEMENTLease Agreement • July 31st, 2020 • Ultragenyx Pharmaceutical Inc. • Pharmaceutical preparations
THIS THIRD AMENDMENT TO LEASE AGREEMENT (the “Third Amendment”) is made as of this 29th day of July, 2019, between ARE-MA REGION NO. 20, LLC, a Delaware limited liability company (“Landlord”), and ULTRAGENYX PHARMACEUTICAL INC., a Delaware corporation (“Tenant”).
